Among teens with headache, 27 percent reported worsening of headaches, while 10 percent had new onset of headache
Vaccination Protects Overweight, Obese Against Severe COVID-19
Protection against severe COVID-19 similar for those with overweight, obesity versus healthy weight; lower protection seen for underweight
Provider Availability Linked to COVID-19 Vaccine Uptake in Children
Vaccination coverage for children aged 5 to 11 higher in counties with at least one active COVID-19 vaccine provider versus no provider
U.S. Orders 105 Million More Pfizer Shots for Fall Booster Campaign
Both Pfizer and Moderna have reported positive results with updated vaccines that target the omicron variant
Two Doses of BNT162b2 Moderately Effective for 5- to 11-Year-Olds
Moderate effectiveness against documented infection and symptomatic COVID-19 for those vaccinated on or after Nov. 23, 2021
COVID-19 Linked to Increased Risk of Neurological Disorders
Most neurological disorders do not appear to be more frequent after COVID-19 than after influenza or bacterial pneumonia
Fauci Has ‘Rebound’ COVID After Paxlovid Treatment
However, director of the NIAID says drug kept him out of the hospital
FDA Tells Vaccine Makers to Update Boosters to Target Omicron Subvariants
Pfizer and Moderna are expected to start producing reformulated doses this summer
ACIP Recommends COVID-19 Vaccines for Children Aged ≥6 Months
ACIP interim recommendations presented for Moderna, Pfizer-BioNTech mRNA vaccines for children aged 6 months to 5 years
FDA Panel Supports Rollout of Tweaked Booster Shots From Moderna, Pfizer This Fall
Advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations